What is the recommended management for typhoid fever?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 6, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Typhoid Fever

For typhoid fever, the recommended first-line treatment is azithromycin 500 mg once daily for 7 days, particularly in areas with high fluoroquinolone resistance. 1

First-Line Treatment Options

  • Azithromycin: 500 mg once daily on day 1, followed by 500 mg once daily for 6 more days (total 7 days) for adults with typhoid fever 1

    • Superior efficacy compared to fluoroquinolones with lower risk of clinical failure (OR 0.48) and shorter hospital stays 1
    • Lower risk of relapse (OR 0.09) compared to ceftriaxone 1
    • Particularly effective against quinolone-resistant strains 1, 2
  • Fluoroquinolones (if local susceptibility is confirmed):

    • Ciprofloxacin 500 mg twice daily for 7-10 days 3
    • Not recommended for cases originating from South Asia due to high resistance rates 4
    • Resistance to nalidixic acid is a marker for decreased susceptibility to ciprofloxacin 5
  • Third-generation cephalosporins:

    • Ceftriaxone (IV): Recommended for severe cases or when oral therapy is not possible 5, 6
    • Typically administered for 7-14 days depending on severity 3

Treatment Algorithm Based on Resistance Patterns

  1. For fully susceptible S. typhi:

    • Fluoroquinolones (ofloxacin or ciprofloxacin) 2
    • Alternatives: chloramphenicol, amoxicillin, or trimethoprim-sulfamethoxazole 2
  2. For multidrug-resistant strains:

    • Fluoroquinolone (if susceptible) or cefixime 2
    • Alternative: azithromycin 2
  3. For quinolone-resistant strains:

    • Azithromycin as preferred treatment 2, 1
    • Alternative: ceftriaxone or cefixime 2

Special Considerations

  • Severe cases: Consider IV ceftriaxone initially, with transition to oral therapy when clinically improved 5, 6
  • Complications: For patients with clinical features of sepsis, broad-spectrum antimicrobial therapy should be started after collection of blood, stool, and urine cultures 5
  • Steroids: May be beneficial in severe cases of typhoid fever 5
  • Treatment duration: 7-14 days is typical, with longer courses for severe infections 3

Monitoring and Follow-up

  • Monitor for clinical response, with expected fever clearance within 4-5 days of appropriate therapy 7, 6
  • Watch for potential drug interactions with azithromycin, particularly with agents metabolized by cytochrome P450 enzyme system 1
  • Common adverse effects of azithromycin include gastrointestinal symptoms: nausea, vomiting, abdominal pain, and diarrhea 1

Treatment Failure Management

  • If poor response to initial therapy, consider:
    • Confirming antimicrobial susceptibility testing if available 1
    • Switching to a third-generation cephalosporin (e.g., ceftriaxone) 1
    • Combination therapy with cefixime may be considered 1

Prevention

  • Typhoid vaccination provides incomplete protection and does not protect against paratyphoid 5
  • Water, sanitation, and hygiene measures are cornerstones of prevention 4

Pitfalls to Avoid

  • Do not use ciprofloxacin empirically for cases originating from South Asia due to high resistance rates 4
  • Ciprofloxacin disc testing is unreliable; the organism should also be sensitive to nalidixic acid to be considered sensitive to fluoroquinolones 5
  • Do not delay treatment when there is strong clinical suspicion, as early treatment results in better outcomes 5
  • Recognize that increasing resistance to fluoroquinolones has been observed, particularly among travelers to South and Southeast Asia 2

References

Guideline

Azithromycin Treatment for Typhoid Fever

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Enteric (typhoid and paratyphoid) fever.

Lancet (London, England), 2025

Guideline

Treatment for Fever with Positive Typhoid Test

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Ceftriaxone therapy in bacteremic typhoid fever.

Antimicrobial agents and chemotherapy, 1985

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.